Carmell Therapeutics Corporation Market Cap ($4.61 Million)
Market Cap & Net Worth: Carmell Therapeutics Corporation (CTCX)
Carmell Therapeutics Corporation market cap. Carmell Therapeutics Corporation (NASDAQ:CTCX) has a market capitalization of $4.61 Million ($4.61 Million) as of November 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #28688 globally and #5897 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Carmell Therapeutics Corporation's stock price $0.15 by its total outstanding shares 30119800 (30.12 Million). Also see CTCX cash generation efficiency for how efficiently the company converts equity into cash flow.
Carmell Therapeutics Corporation Market Cap History (2021–2025)
Carmell Therapeutics Corporation market cap history from 2021 to 2025. Data shows change from $289.75 Million to $4.61 Million (-68.19% CAGR). Check CTCX stock price for real-time trading data and today's change.
Index Memberships
Carmell Therapeutics Corporation is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Composite
IXIC
|
$39.84 Trillion | 0.00% | #2638 of 3165 |
Weight: Carmell Therapeutics Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Carmell Therapeutics Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Carmell Therapeutics Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Carmell Therapeutics Corporation (CTCX) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
167.07x
Carmell Therapeutics Corporation's market cap is 167.07 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $8.41 Million | $50.32K | -$10.37 Million | 167.07x | N/A |
Competitor Companies of CTCX by Market Capitalization
Companies near Carmell Therapeutics Corporation in the global market cap rankings as of November 3, 2026. Also see CTCX total assets for a full breakdown of the balance sheet.
Key companies related to Carmell Therapeutics Corporation by market ranking:
- Procter & Gamble Company (NYSE:PG): Ranked #39 globally with a market cap of $373.42 Billion USD.
- LOREAL ADR 1/5/EO 02 (F:LORA): Ranked #98 globally with a market cap of $204.17 Billion USD ( €174.64 Billion EUR).
- LOréal S.A. (PA:OR): Ranked #99 globally with a market cap of $204.16 Billion USD ( €174.63 Billion EUR).
- Unilever PLC (NASDAQ:UNLYD): Ranked #200 globally with a market cap of $120.76 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #39 | Procter & Gamble Company | NYSE:PG | $373.42 Billion | $163.56 |
| #98 | LOREAL ADR 1/5/EO 02 | F:LORA | $204.17 Billion | €72.00 |
| #99 | LOréal S.A. | PA:OR | $204.16 Billion | €436.50 |
| #200 | Unilever PLC | NASDAQ:UNLYD | $120.76 Billion | $55.38 |
Market Capitalization of Carmell Therapeutics Corporation (2021–2025)
Market capitalization of Carmell Therapeutics Corporation from 2021 to today. Between 2021 and today, Carmell Therapeutics Corporation's market cap moved from $289.75 Million to $ 4.61 Million, with a yearly change of -68.19%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $4.61 Million | -45.18% |
| 2024 | $8.41 Million | -92.67% |
| 2023 | $114.76 Million | -61.58% |
| 2022 | $298.70 Million | +3.09% |
| 2021 | $289.75 Million | -- |
End of Day Market Cap According to Different Sources
On May 8th, 2026 the market cap of Carmell Therapeutics Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.61 Million USD |
| MoneyControl | $4.61 Million USD |
| MarketWatch | $4.61 Million USD |
| marketcap.company | $4.61 Million USD |
| Reuters | $4.61 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Carmell Therapeutics Corporation
Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on … Read more